1)  Budd-Chiari Syndrome
布卡综合征
1.
Study on Fibrinogen Related Budd-Chiari Syndrome and Takayasus Arteritis;
布卡综合征和多发性大动脉炎纤维蛋白原的对照研究
2.
The Study of Etiology of Budd-Chiari Syndrome;
布卡综合征的病因学研究
3.
Objective To introduce etiological hypothes is of Budd-Chiari Syndrome(BCS) in China by analyzing the distribution of BCS in Henan province.
目的通过对河南省布卡综合征(Budd-Chiari Syndrome,BCS)患者分布的分布并提出该病病因假设。
2)  Budd-Chiari Syndrome
Budd-Chiari Syndrome
1.
Objective To understand the relationship between Budd-Chiari Syndrome(BCS) and inflammatory by White Blood Cell (WBC) Count of patients with BCS and lower limb thrombosis.
目的通过对布卡综合征(Budd-Chiari Syndrome,BCS)患者和下肢血栓患者白细胞(White Blood Cell,WBC)计数分析来了解我国BCS与炎症间的关系。
3)  Budd-Chiari Syndrome
布六综合征
4)  Budd-Chiari syndrome
布-加氏综合征
1.
Characteristic changes of patients with Budd-Chiari syndrome detected by ultrasound;
布-加氏综合征的超声特征性变化
2.
Nursing of Budd-Chiari syndrome before and after the operation;
布-加氏综合征手术前后的护理
3.
Interventional treatment in 178 cases with Budd-Chiari syndrome;
178例布-加氏综合征的介入治疗
5)  Budd-Chiari syndrome
布加氏综合征
1.
The Clinical Application of Color Doppler Ultrasonography-diagnostic Technique for Budd-Chiari Syndrome;
彩色多普勒超声在布加氏综合征诊断中的临床应用
2.
Establishment of the Budd-Chiari syndrome model with hepaticvenous stenosis;
肝静脉阻塞型布加氏综合征动物模型的制作
3.
The follow-up of the patients with Budd-Chiari syndrome receiving radical operation through midsternal incision approach;
胸部正中切口布加氏综合征根治术远期疗效观察
6)  Budd-Chiari syndrome
布-卡氏综合征
参考词条
补充资料：狄布卡因
分子式：C20H29N3O2·HCl
分子量：379.92
CAS号：61-12-1

性质：白色结晶性粉末。熔点94-96℃。易溶于水（1份该品溶于0.5份水），极易溶于乙醇、丙酮、氯仿，微溶于苯，不溶于醚。味略苦，有潮解性，遇光变质。

制备方法：2-羟基喹啉羧酸经氯化、缩合、丁醚化、成盐得到辛可卡因。

用途：该品属酰胺类麻醉药，临床应用的局麻药中，辛可卡因是作用最强、毒性最大、维持时间最长的一种。注射给药的麻醉强度是普鲁卡因的15倍，毒性也大15倍。起效较慢，约15min，但持续作用时间为普鲁卡因的3倍。局部刺激性小，穿透力较强。用于表面麻醉、浸润麻醉或硬脊膜外麻醉。

说明：补充资料仅用于学习参考，请勿用于其它任何用途。